ArticleAnnals of hematology2025
Initial local treatment strategies on survival outcomes of early-stage breast mucosa-associated lymphoid tissue lymphoma.
Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
To compare survival outcomes among different initial treatment strategies for early-stage (stage I-II) breast mucosa-associated lymphoid tissue (MALT) lymphoma. Using data from the Surveillance, Epidemiology, and End Results program, we analyzed patients diagnosed with early-stage breast MALT lymphoma between 2000 and 2017. Statistical analyses included chi-square tests, Kaplan-Meier survival estimates, and multivariate Cox proportional-hazards models. Among 396 eligible patients, treatment strategies included surgery with or without postoperative radiotherapy (161 patients, 40.7%), radiotherapy alone (122 patients, 30.8%), and observation (113 patients, 28.5%). Temporal trends indicated increasing use of radiotherapy alone, while surgery alone and observation declined (P = 0.061). With a median follow-up of 94 months, the 8-year cancer-specific survival (CSS) and overall survival (OS) rates were 88.7% and 71.9%, respectively. Patients receiving local treatment (surgery and/or radiotherapy) alone demonstrated superior CSS (P = 0.002) and OS (P < 0.001) compared to observation. However, adding chemotherapy to local treatment was associated with worse CSS (P = 0.017) and OS (P = 0.003). Sensitivity analysis revealed no significant differences in CSS or OS among local treatment modalities (surgery alone, radiotherapy alone, or combined surgery and radiotherapy). Radiotherapy alone can achieve the optimal disease control for early-stage breast MALT lymphoma. The role of surgery is rather limited and is mainly considered when there is a diagnostic dilemma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.